Viewing Study NCT06790420


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-02-25 @ 6:43 PM
Study NCT ID: NCT06790420
Status: COMPLETED
Last Update Posted: 2025-05-31
First Post: 2025-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module